Literature DB >> 9176165

Different interactions of cardiac and skeletal muscle ryanodine receptors with FK-506 binding protein isoforms.

S Barg1, J A Copello, S Fleischer.   

Abstract

In the present study, we compare functional consequences of dissociation and reconstitution of binding proteins FKBP12 and FKBP12.6 with ryanodine receptors from cardiac (RyR2) and skeletal muscle (RyR1). The skeletal muscle RyR1 channel became activated on removal of endogenously bound FKBP12, consistent with previous reports. Both FKBP12 and FKBP12.6 rebind to FKBP-depleted RyR1 and restore its quiescent channel behavior by altering ligand sensitivity, as studied by single-channel recordings in planar lipid bilayers, and macroscopic behavior of the channels (ryanodine binding and net energized Ca2- uptake). By contrast, removal of FKBP12.6 from the cardiac RyR2 did not modulate the function of the channel using the same types of assays as for RyR1. FKBP12 or FKBP12.6 had no effect on channel activity of FKBP12.6-depleted cardiac RyR2, although FKBP12.6 rebinds. Our studies reveal important differences between the two ryanodine receptor isoforms with respect to their functional interaction with FKBP12 and FKBP12.6.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176165     DOI: 10.1152/ajpcell.1997.272.5.C1726

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  37 in total

1.  FKBP12 modulation of the binding of the skeletal ryanodine receptor onto the II-III loop of the dihydropyridine receptor.

Authors:  Fiona M O'Reilly; Mylène Robert; Istvan Jona; Csaba Szegedi; Mireille Albrieux; Sandrine Geib; Michel De Waard; Michel Villaz; Michel Ronjat
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

Review 2.  Protein-protein interactions in intracellular Ca2+-release channel function.

Authors:  J J MacKrill
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  Voltage change-induced gating transitions of the rabbit skeletal muscle Ca2+ release channel.

Authors:  A Zahradníková; L G Meszáros
Journal:  J Physiol       Date:  1998-05-15       Impact factor: 5.182

4.  Heterogeneity of Ca2+ gating of skeletal muscle and cardiac ryanodine receptors.

Authors:  J A Copello; S Barg; H Onoue; S Fleischer
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

Review 5.  FK506-binding proteins 12 and 12.6 (FKBPs) as regulators of cardiac Ryanodine Receptors: Insights from new functional and structural knowledge.

Authors:  Luis A Gonano; Peter P Jones
Journal:  Channels (Austin)       Date:  2017-06-21       Impact factor: 2.581

6.  Sensitized signalling between L-type Ca2+ channels and ryanodine receptors in the absence or inhibition of FKBP12.6 in cardiomyocytes.

Authors:  Yan-Ting Zhao; Yun-Bo Guo; Lei Gu; Xue-Xin Fan; Hua-Qian Yang; Zheng Chen; Peng Zhou; Qi Yuan; Guang-Ju Ji; Shi-Qiang Wang
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

7.  Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks.

Authors:  Tao Guo; Razvan L Cornea; Sabine Huke; Emmanuel Camors; Yi Yang; Eckard Picht; Bradley R Fruen; Donald M Bers
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

8.  Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes.

Authors:  Cindy R Sinars; Joyce Cheung-Flynn; Ronald A Rimerman; Jonathan G Scammell; David F Smith; Jon Clardy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

9.  Regulation by FK506 and rapamycin of Ca2+ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR.

Authors:  D MacMillan; J G McCarron
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

Review 10.  Dysregulated sarcoplasmic reticulum calcium release: potential pharmacological target in cardiac disease.

Authors:  Sandor Györke; Cynthia Carnes
Journal:  Pharmacol Ther       Date:  2008-07-12       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.